241 related articles for article (PubMed ID: 32326899)
21. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
[TBL] [Abstract][Full Text] [Related]
22. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
[TBL] [Abstract][Full Text] [Related]
23. Growth regulatory factors and signalling proteins in testicular germ cell tumours.
Devouassoux-Shisheboran M; Mauduit C; Tabone E; Droz JP; Benahmed M
APMIS; 2003 Jan; 111(1):212-24; discussion 224. PubMed ID: 12752264
[TBL] [Abstract][Full Text] [Related]
24. Activin and BMP Signalling in Human Testicular Cancer Cell Lines, and a Role for the Nucleocytoplasmic Transport Protein Importin-5 in Their Crosstalk.
Radhakrishnan K; Luu M; Iaria J; Sutherland JM; McLaughlin EA; Zhu HJ; Loveland KL
Cells; 2023 Mar; 12(7):. PubMed ID: 37048077
[TBL] [Abstract][Full Text] [Related]
25. Endogenous Nodal signaling regulates germ cell potency during mammalian testis development.
Spiller CM; Feng CW; Jackson A; Gillis AJ; Rolland AD; Looijenga LH; Koopman P; Bowles J
Development; 2012 Nov; 139(22):4123-32. PubMed ID: 23034635
[TBL] [Abstract][Full Text] [Related]
26. Activin A target genes are differentially expressed between normal and neoplastic adult human testes: clues to gonocyte fate choice.
Szarek M; Bergmann M; Konrad L; Schuppe HC; Kliesch S; Hedger MP; Loveland KL
Andrology; 2019 Jan; 7(1):31-41. PubMed ID: 30315637
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer.
Pierpont TM; Lyndaker AM; Anderson CM; Jin Q; Moore ES; Roden JL; Braxton A; Bagepalli L; Kataria N; Hu HZ; Garness J; Cook MS; Capel B; Schlafer DH; Southard T; Weiss RS
Cell Rep; 2017 Nov; 21(7):1896-1909. PubMed ID: 29141221
[TBL] [Abstract][Full Text] [Related]
28. The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines.
Schweyer S; Soruri A; Heintze A; Radzun HJ; Fayyazi A
Int J Oncol; 2004 Dec; 25(6):1671-6. PubMed ID: 15547704
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy.
Singh R; Fazal Z; Bikorimana E; Boyd RI; Yerby C; Tomlin M; Baldwin H; Shokry D; Corbet AK; Shahid K; Hattab A; Freemantle SJ; Spinella MJ
Mol Oncol; 2022 Feb; 16(3):683-698. PubMed ID: 34482638
[TBL] [Abstract][Full Text] [Related]
30. Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells.
Steinemann G; Dittmer A; Kuzyniak W; Hoffmann B; Schrader M; Schobert R; Biersack B; Nitzsche B; Höpfner M
Mol Cancer Ther; 2017 Nov; 16(11):2364-2374. PubMed ID: 28838999
[TBL] [Abstract][Full Text] [Related]
31. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
32. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
33. miRNA-302s may act as oncogenes in human testicular germ cell tumours.
Das MK; Evensen HSF; Furu K; Haugen TB
Sci Rep; 2019 Jun; 9(1):9189. PubMed ID: 31235829
[TBL] [Abstract][Full Text] [Related]
34. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.
Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X
Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
[TBL] [Abstract][Full Text] [Related]
36. A Genetically Engineered Mouse Model of Malignant Testicular Germ Cell Tumors.
Lyndaker AM; Pierpont TM; Loehr AR; Weiss RS
Methods Mol Biol; 2021; 2195():147-165. PubMed ID: 32852763
[TBL] [Abstract][Full Text] [Related]
37. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
38. Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours.
Funke K; Einsfelder U; Hansen A; Arévalo L; Schneider S; Nettersheim D; Stein V; Schorle H
Br J Cancer; 2023 Jun; 128(12):2270-2282. PubMed ID: 37024667
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L
Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254
[TBL] [Abstract][Full Text] [Related]
40. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.
Kerley-Hamilton JS; Pike AM; Li N; DiRenzo J; Spinella MJ
Oncogene; 2005 Sep; 24(40):6090-100. PubMed ID: 15940259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
